BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 23335253)

  • 1. Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement.
    Truchetet ME; Brembilla NC; Montanari E; Lonati P; Raschi E; Zeni S; Fontao L; Meroni PL; Chizzolini C
    Arthritis Rheum; 2013 May; 65(5):1347-56. PubMed ID: 23335253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
    Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transdifferentiation of fibroblasts into myofibroblasts in the skin lesion of systemic sclerosis: role of transforming growth factor β1 and its signal transduction].
    Liu T; Hu XD
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1840-5. PubMed ID: 22126761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis.
    Artlett CM; Sassi-Gaha S; Rieger JL; Boesteanu AC; Feghali-Bostwick CA; Katsikis PD
    Arthritis Rheum; 2011 Nov; 63(11):3563-74. PubMed ID: 21792841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis.
    Lonati PA; Brembilla NC; Montanari E; Fontao L; Gabrielli A; Vettori S; Valentini G; Laffitte E; Kaya G; Meroni PL; Chizzolini C
    PLoS One; 2014; 9(8):e105008. PubMed ID: 25136988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of PDGF-A/PDGFR-α in proliferation and transdifferentiation of fibroblasts from skin lesions of patients with systemic sclerosis].
    Liu T; Zhang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr; 32(4):496-501. PubMed ID: 22543129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the fibroblast proliferation and transdifferentiation for myofibroblast from skin lesion of the patients with systemic sclerosis repressed by H2 Relaxin].
    Liu T; Hu XD
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Dec; 27(12):1312-4, 1318. PubMed ID: 22152813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential roles of interleukin-17A in the development of skin fibrosis in mice.
    Okamoto Y; Hasegawa M; Matsushita T; Hamaguchi Y; Huu DL; Iwakura Y; Fujimoto M; Takehara K
    Arthritis Rheum; 2012 Nov; 64(11):3726-35. PubMed ID: 22833167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis.
    Kissin EY; Merkel PA; Lafyatis R
    Arthritis Rheum; 2006 Nov; 54(11):3655-60. PubMed ID: 17075814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.
    Jelaska A; Korn JH
    Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions.
    Mathian A; Parizot C; Dorgham K; Trad S; Arnaud L; Larsen M; Miyara M; Hié M; Piette JC; Frances C; Yssel H; Amoura Z; Gorochov G
    Ann Rheum Dis; 2012 Jul; 71(7):1227-34. PubMed ID: 22696687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1.
    Dufour AM; Alvarez M; Russo B; Chizzolini C
    Front Immunol; 2018; 9():1865. PubMed ID: 30150989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
    Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
    Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis.
    Martin P; Teodoro WR; Velosa AP; de Morais J; Carrasco S; Christmann RB; Goldenstein-Schainberg C; Parra ER; Katayama ML; Sotto MN; Capelozzi VL; Yoshinari NH
    Autoimmun Rev; 2012 Sep; 11(11):827-35. PubMed ID: 22406224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts.
    Fineschi S; Cozzi F; Burger D; Dayer JM; Meroni PL; Chizzolini C
    Rheumatology (Oxford); 2007 Dec; 46(12):1779-85. PubMed ID: 17982166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated matrix metalloproteinase-9 in patients with systemic sclerosis.
    Kim WU; Min SY; Cho ML; Hong KH; Shin YJ; Park SH; Cho CS
    Arthritis Res Ther; 2005; 7(1):R71-9. PubMed ID: 15642145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.